Europe Proteomics Market - Segmented by Technology, Services, Application and by Geography - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Europe Proteomics Market is Segmented by Instrumentation Technology, Services and Software, Reagents, Application (Clinical Diagnostics, Drug Discovery, Other Applications), and Geography

Market Snapshot

Study Period:

2018 - 2026

Base Year:

2019

CAGR:

16.9 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Proteomics, over the last decade, has gained importance in the field of diagnosis, drug research, and development. It has various applications ranging from identification of proteins to purification and separation of the protein to study the nature and properties. It has vast applications in identifying some protein-related disorders or diseases in the organism. Thus, it is evolving into an important tool in the field of life sciences.

Furthermore, increasing demand for personalized medicine in Europe along with the presence of key market player such as Merck Co KgA expected to boost regional growth. In addition, positive support from the local authorities in Europe along with the initiatives by research organizations to advance the proteomics technologies such as chemo proteomics, spectrometry are expected to further fuel the market growth. For instance, In 2018 a Thermo Fisher Scientific and Denmark-based Symphogen have collaborated to accelerate innovations in biopharmaceutical characterization. Under the collaboration, companies are planned to develop validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.

Scope of the report

Proteomics is the study of protein structure and function. At the cellular level, proteomics deal with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.

By Type
By Instrumentation Technology
Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Other Instrumentation Technologies
By Services and Software
Core Proteomics Services
Bioinformatics Software and Services
By Reagents
By Application
Clinical Diagnostics
Drug Discovery
Other Applications
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug Discovery is Expected to Have Notable Growth Rate

  • The identification of potential new drugs for the treatment of disease has been considered one of the most promising developments in the study of human genes and proteins. This depends on genome and proteome information for the identification of proteins, associated with a disease, which can then be used as targets for new drugs by computer software.
  • The growing spending on the drug discovery and development by the pharma and biopharmaceutical companies along with research organizations in the region is the primary factor for segment growth
  • For instance, as per Study published in the National Center for Biotechnology Information, in the years 2017-2018, the Association of Medical Research Charities (AMRC) contributed 41% of non-industry spend on research and development in the United Kingdom, while the Medical Research Council and National Institute for Health research contributed 26% and 33% respectively. In addition, increasing investment in life sciences research and the United Kingdom governments’ ambition to increase R&D spending to 2.4 per cent of GDP by 2027 and 3 per cent over the longer term.
  • All these factors are projected to boost the market growth for proteomics in the Europe.

To understand key trends, Download Sample Report

Competitive Landscape

The European proteomics market is highly competitive and consists of a number of major players. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation, among others.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Expenditure and Government Funding for Proteomics

      2. 4.2.2 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Instruments

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 By Instrumentation Technology

        1. 5.1.1.1 Spectroscopy

        2. 5.1.1.2 Chromatography

        3. 5.1.1.3 Electrophoresis

        4. 5.1.1.4 Protein Microarrays

        5. 5.1.1.5 X-Ray Crystallography

        6. 5.1.1.6 Other Instrumentation Technologies

      2. 5.1.2 By Services and Software

        1. 5.1.2.1 Core Proteomics Services

        2. 5.1.2.2 Bioinformatics Software and Services

      3. 5.1.3 By Reagents

    2. 5.2 By Application

      1. 5.2.1 Clinical Diagnostics

      2. 5.2.2 Drug Discovery

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 Europe

        1. 5.3.1.1 Germany

        2. 5.3.1.2 United Kingdom

        3. 5.3.1.3 France

        4. 5.3.1.4 Italy

        5. 5.3.1.5 Spain

        6. 5.3.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies, Inc.

      2. 6.1.2 Bio-Rad Laboratories, Inc.

      3. 6.1.3 Thermo Fisher Scientific, Inc.

      4. 6.1.4 GE Healthcare

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 Waters Corporation

      7. 6.1.7 Promega Corporation

      8. 6.1.8 Merck KGaA

      9. 6.1.9 Bruker Corporation

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports